Red Cat Launches €205 Million Cash Bid for Austria’s Steyr Motors
Deal backed by major shareholder, targets Blue Ops maritime growth.
Already have an account? Sign in.
Deal backed by major shareholder, targets Blue Ops maritime growth.
The deal expands credit trading from issuance to secondary markets and is expected to be accretive.
FDA grants accelerated approval to Jemperli for stage II/III MSI-H/dMMR rectal cancer, sending AnaptysBio stock higher on royalty potential.
Deal not confirmed.
Be the first to know when deals break, stocks move, or biotech headlines hit.